View in EDS

Reply to X. Luo et al.

Saved in:
Bibliographic Details
Title: Reply to X. Luo et al.
Authors: Giri VN; Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA., Oliver TK; Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA., Rumble RB; Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA., Geisel RL; Veda N. Giri, MD, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Thomas K. Oliver, BA, R. Bryan Rumble, MSc, and Rachel L. Geisel, BS, American Society of Clinical Oncology, Alexandria, VA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 10; Vol. 41 (5), pp. 1150-1151. Date of Electronic Publication: 2022 Oct 31.
Publication Type: Journal Article; Comment
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.22.02126